Topical testosterone most commonly causes skin problems like itching or rash. In those with female anatomy, specifically, it can cause unwanted hair growth, acne, or birth defects in pregnant people.

AUSTIN, Texas — Fewer than one in five hypogonadal men are adherent to prescribed topical testosterone, new research indicates. The findings, from a large commercial insurance database, were presented ...

The study evaluated adherence to topical testosterone therapy in a real-world cohort of commercially insured males with primary or secondary hypogonadism. This article is written live from the ...

ARSYNL Rx Launches Exclusive HypoSpray® Transdermal Testosterone Option, Marking a New Era in Hormone Support Dover, United ...

INDIANAPOLIS, April 1, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Axiron® (testosterone) topical solution is available in pharmacies throughout the United States.

Findings compared with exercise therapy alone or usual care among older women. (HealthDay News) — Topical testosterone therapy does not significantly improve functional outcomes beyond supervised ...

INDIANAPOLIS, June 28, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that a pivotal Phase III Axiron study, published on the Clinical Endocrinology website, showed that Axiron® ...

HealthDay News — Application of once-daily topical testosterone effectively restores normal testosterone levels in men, according to a study published in the March issue of The Journal of Urology.

INDIANAPOLIS, IN and MELBOURNE, AUSTRALIA -- Eli Lilly and Company (NYSE:LLY) and Acrux (ASX: ACR) announced that the U.S. Food and Drug Administration (FDA) has approved Axiron® (testosterone) ...

Findings compared with exercise therapy alone or usual care among older women. HealthDay News — Topical testosterone therapy does not significantly improve functional outcomes beyond supervised ...